R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an …
Over the last 12 months, insiders at R1 RCM Inc. have bought $0 and sold $436.44M worth of R1 RCM Inc. stock.
On average, over the past 5 years, insiders at R1 RCM Inc. have bought $519,599 and sold $335.58M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 71,767 shares for transaction amount of $1M was made by RIVAS LEE (Chief Executive Officer) on 2023‑02‑21.
2024-11-19 | Sale | 30.55M 7.2181% | $14.28 | $436.29M | +0.20% | |||
2024-03-07 | Sale | President | 10,046 0.0024% | $14.33 | $143,959 | -7.75% | ||
2023-08-08 | Sale | director | 50,000 0.0119% | $17.17 | $858,650 | -27.68% | ||
2023-06-12 | Sale | Principal Accounting Officer | 17,000 0.0041% | $16.84 | $286,229 | -25.33% | ||
2023-06-09 | Sale | Principal Accounting Officer | 12,000 0.0029% | $16.69 | $200,280 | -24.43% | ||
2023-05-10 | Sale | President | 20,000 0.0048% | $16.36 | $327,280 | -20.56% | ||
2023-02-21 | Chief Executive Officer | 71,767 0.0173% | $13.93 | $1M | +7.13% | |||
2022-09-13 | Sale | 15M 3.5213% | $20.43 | $306.38M | -24.32% | |||
2022-08-19 | Sale | See Remarks | 40,000 0.0095% | $25.01 | $1M | -37.53% | ||
2022-08-16 | Sale | Chief Executive Officer | 3,409 0.0008% | $25.91 | $88,344 | -37.76% | ||
2022-08-10 | Sale | Principal Accounting Officer | 15,000 0.0036% | $26.02 | $390,300 | -39.48% | ||
2022-08-10 | Sale | See Remarks | 189,869 0.0453% | $25.94 | $4.93M | -39.48% | ||
2022-08-09 | Sale | See Remarks | 4,365 0.0011% | $26.03 | $113,612 | -38.71% | ||
2022-08-08 | Sale | Principal Accounting Officer | 10,000 0.0024% | $26.77 | $267,720 | -40.62% | ||
2022-08-05 | Sale | See Remarks | 48,047 0.0117% | $26.84 | $1.29M | -40.54% | ||
2022-08-05 | Sale | 10,318 0.0024% | $26.18 | $270,136 | -40.54% | |||
2021-11-18 | Sale | director | 140,829 0.0531% | $25.40 | $3.58M | -8.60% | ||
2021-11-17 | Sale | director | 34,171 0.0128% | $25.60 | $874,641 | -9.24% | ||
2021-11-11 | Sale | President and CEO | 93,931 0.0354% | $25.60 | $2.4M | -8.59% | ||
2021-11-10 | Sale | President and CEO | 62,563 0.0235% | $25.28 | $1.58M | -7.75% |
FLANAGAN JOSEPH GERARD | Chief Executive Officer | 2792221 0.661% | $14.31 | 2 | 8 | +100.16% |
SHULMAN STEVEN J | director | 2450000 0.58% | $14.31 | 1 | 0 | |
RICAURTE CHRISTOPHER SIMON | Chief Financial Officer | 311902 0.0738% | $14.31 | 1 | 0 | |
MANDL ALEX | director | 93871 0.0222% | $14.31 | 2 | 2 | |
HENNEMAN JOHN B III | director | 72114 0.0171% | $14.31 | 1 | 1 |
New Mountain Capital L L C | $1.22B | 22.41 | 94.41M | 0% | +$0 | 77.26 | |
BlackRock | $214.69M | 3.96 | 16.67M | -0.69% | -$1.49M | 0.01 | |
The Vanguard Group | $194.21M | 3.58 | 15.08M | -0.78% | -$1.52M | <0.01 | |
Coliseum Capital Management, LLC | $132.33M | 2.44 | 10.27M | +94.07% | +$64.14M | 12.2 | |
Voss Capital LLC | $118.63M | 2.19 | 9.21M | +29.27% | +$26.86M | 9.8 |